Kilci, F. Et Al. 2021. Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab. 23rd European Congress of Endocrinology 2021 , (Bristol, United Kingdom), 162.

Kilci, F., Demirsoy, U., Jones, J. H., & Çizmecioğlu Jones, F. M., (2021). Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab . 23rd European Congress of Endocrinology 2021 (pp.162). Bristol, United Kingdom

Kilci, FATİH Et Al. "Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab," 23rd European Congress of Endocrinology 2021, Bristol, United Kingdom, 2021

Kilci, FATİH Et Al. "Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab." 23rd European Congress of Endocrinology 2021 , Bristol, United Kingdom, pp.162, 2021

Kilci, F. Et Al. (2021) . "Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab." 23rd European Congress of Endocrinology 2021 , Bristol, United Kingdom, p.162.

@conferencepaper{conferencepaper, author={FATİH KİLCİ Et Al. }, title={Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: A new treatment strategy with Zoledronic Acid and Denosumab}, congress name={23rd European Congress of Endocrinology 2021}, city={Bristol}, country={United Kingdom}, year={2021}, pages={162} }